Advanced Practice Midwife in Terre Haute, IN Accepting Medicare

2 Advanced Practice Midwife nurses found. Showing 1 - 2

Bethel C Bose, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1801 N 6th St, Suite 200, Terre Haute, IN 47804 Phone: 812-238-7301    Fax: 812-238-7056

Ruthann Y Mishler, CNMW Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1801 N 6th St, Suite 200, Terre Haute, IN 47804 Phone: 812-238-7301    Fax: 812-238-7056

News Archive

Japanese health authorities approve Aerocrine's NIOX MINO for assessing airway inflammation

Aerocrine AB announces today that Japanese health authorities have approved the use of its FeNO-measuring device NIOX MINO as a tool for assessing patients with airway inflammation such as asthma.

IGRT offers improved treatment results for obese prostate cancer patients

Moderately to severely obese prostate cancer patients may have improved treatment outcomes when treated with image-guided radiation therapy (IGRT) over traditional external beam radiation therapy (EBRT) because IGRT corrects for prostate shifts, which, if not planned for, can lead to incorrect doses of radiation to the disease site, according to a study in the September 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

Concordia study investigates the link between cognition and hearing or vision loss

There is a long-established and widely recognized link between declines in sensory acuity - particularly hearing and vision - and cognition. Data from the Canadian Longitudinal Study on Aging, involving tens of thousands of participants across the country aged 45 to 85, backs this up.

SkinVision algorithm detects 95% of skin cancer, study finds

An international group of researchers working with Erasmus University Medical Center (Erasmus MC) in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer.

Gene responsible for management of glutamate is a promising candidate in determining risk for schizophrenia

Researchers at the National Institute of Mental Health have identified a relationship between a small section of one gene, the brain chemical messenger glutamate, and a collection of traits known to be associated with schizophrenia.

Read more Medical News

› Verified 3 days ago